Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Type & End-User The global POC blood gas and electrolyte market will witness a robust CAGR of 7.89%, valued at $1.08 billion in 2021, expected to appreciate and reach $4.16 billion by 2030, confirms Strategic Market Research. The point of care (POC) blood gas and electrolyte system is an exquisite concept that has been presented in the realm of critical care settings to provide patients with decentralized, patient-centric health care systems. Different parameters of blood samples, such as blood gas (pCO2 and pO2), pH, electrolytes, and different abnormal rates of metabolites present in the blood, can be measured using point-of-care blood gas and electrolytic analyzers. Moreover, the post venous blood gas with lactate measurement has a long history of clinical use as a blood marker of tissue hypoxia, mostly in assessing and monitoring critically sick patients in the emergency rooms and intensive care units. The gold standard sample for lactate measurement is arterial blood. However, the current practice suggests that venous blood is a viable option. Also, Patients with diabetes are monitored with post blood sugar tests at the bedside, at home, or in the hospital. These technologies are significant in the healthcare industry because they reduce the therapy turnaround time, improve patient happiness, provide accuracy and speed of point-of-care electrolyte testing, and improve hospital operations. As a result, emergency cases have increased significantly, resulting in a strong demand for analyzers. According to the American Lung Association, 9.0 million individuals, or 3.6 per cent of those aged 18 and above, had chronic bronchitis in 2018. Moreover, chronic diseases account for seven out of ten fatalities in the United States, killing more than 1.7 million people each year, according to the World Health Organization. Furthermore, according to the World Health Organization, 38.3 million children were overweight or obese in 2019. These disorders are the primary reason for the enormous increase in care in NICUs, ICUs, CVORs, and emergency departments. POC Blood Gas And Electrolyte Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 2.10 billion Revenue forecast in 2030 USD 4.16 billion Growth rate CAGR of 7.89 % The base year for estimation 2021 Historical data 2015 – 2019 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Type, Based on End-User and By region. Based on Type Consumables (Cartridges, Reagents, Others), Instruments (Benchtop, Portable). Based on End-User Hospitals and Clinics, Home Care, Research Institutes, Others By Region North America, Europe, Asia-Pacific, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Nova Biomedical,Bayer,Fortress Diagnostics,Edan Instruments,F. Hoffmann-La Roche,Erba Diagnostics,Medica,Radiometer,JOKOH,Abbott,Convergent Technologies,LifeHealth,Instrumentation Laboratory,Cornley. Pricing and purchase options Customized buying options are available to meet your exact research needs. Market Drivers The point-of-care blood gas and electrolyte devices market has grown as the number of treatments in NICUs, ICUs, CVORs, and emergency rooms has increased. Market growth is fueled by increased cancer and other chronic illness rates. Market Restraint The high complexity involved in the interpretation of blood gas analysis hinders the growth of the market. The necessity of replacing terminals, pump tubes, and valves used in POC blood gas and electrolyte products adds a massive expense in clinics and laboratories, thus, negatively affecting round-the-clock operations. As a result, this high cost of replacement and maintenance can restrain the growth of the market. Market Opportunity Increasing investment in the compact point-of-care blood gas analyzer that provides faster results and addresses the needs of critical care services, operating rooms, and emergency healthcare services will further drive global demand. As the world population ages, the usage of POC devices in hospitals, emergency rooms, and diagnostic centres will expand, thereby playing a vital role in developing the market. Market Analysis Of Different Segments Covered in the Report By Type Consumables Cartridges Reagents Others Instruments Benchtop Portable By End-User Hospitals and Clinics Home Care Research Institutes Others By Region North America U.S. Canada Mexico Europe Germany France Italy Switzerland UK Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA By Type, the consumables segment has the highest market share, while the instruments segment is expected to grow at a growth rate of 6.3 per cent over the estimated period. By end-users, hospitals and clinics dominated the global market, accounting for about 58.4% of the worldwide market in 2020. North America dominated the market growth covering an overall share of 41.79 per cent of the entire market across the globe in 2020. Because of the large patient population with the rising prevalence of chronic diseases such as kidney, diabetes, and liver disease, and increasing government support for R&D, the market in North America is expected to generate significant business opportunities for vendors during the forecasted period. According to the Centers for Disease Control and Prevention (CDC), diabetes affected 30.3 million individuals in the United States in 2015. Due to the well-developed healthcare industry, substantial government funding for research and development, and high healthcare expenditure, Europe is the second-largest market, followed by the Asia Pacific. Growing healthcare costs and a rapidly growing diabetic and obese population is boosting the growth of the Asia Pacific Market. According to the World Health Organization, 60% of the world's diabetes population resides in the Asia Pacific region. Japan and Canada are two other critical geographic markets, with forecasted growth rates of 4.1 per cent and 4.3 per cent, respectively, over the projected period. Moreover, Germany is expected to expand at a CAGR of around 4.7 per cent in Europe. POC Blood Gas And Electrolyte Market Competitive Landscape Analysis Nova Biomedical Bayer Fortress Diagnostics Edan Instruments F. Hoffmann-La Roche Erba Diagnostics Medica Radiometer JOKOH Abbott Convergent Technologies LifeHealth Instrumentation Laboratory Cornley Recent Developments June 2021- PCR testing of symptomatic and asymptomatic persons was granted the first FDA Emergency Use Authorization by the Roche SARS-CoV-2 molecular test. On May 2021, Roche launched a new blood gas digital solution to improve patient care. On January 2021, The Nova Biomedical FLEX2 Cell Culture Analyzer added sample retention capability. The key POC Blood Gas and Electrolyte Devices that are developed by Market Leaders Name of the product Function Key Players EasyBloodGas It helps address the laboratory's need to deliver the blood sample results at a lower cost. Medica Corporation Convergys liquical It is used for testing blood gases, electrolytes, and metabolites on 27 different parameters. Convergent Technologies CHOLESTECH LDX ANALYZER It provides accurate and readily accessible results in point-of-care lipid profile, cholesterol, and glucose testing. Abbott Frequently Asked Question About This Report Who are the leading key players operating in the market? Key players profiled in the market include Nova Biomedical, Bayer, Fortress Diagnostics, Edan Instruments, F. Hoffmann-La Roche, Erba Diagnostics, Medica, Radiometer, JOKOH, Abbott, Convergent Technologies, LifeHealth, Instrumentation Laboratory, Cornley. Which region has the largest market share? The North American region has the largest share of the market. Which is the leading end-user for market? Hospitals and clinics are the leading end-user for the market. What is the CAGR rate for the market over the forecasted period? The market is predicted to increase at a 7.89% CAGR between 2021-2030. What is the POC blood gas and electrolyte market growth? The global POC blood gas and electrolyte market is expected to grow at a compound annual growth rate (CAGR) of 7.89% from 2021 to 2030 to reach USD 4.16 Billion by 2030. How big is the POC blood gas and electrolyte market? The global POC blood gas and electrolyte market size was $2.10 Bn in 2021 and is predicted to reach $4.16 Bn by 2030, with a CAGR of 7.89%. Sources:- https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-prevalence https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html 1. Introduction 1.1. Study Objective 1.2. market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 market Summary 4. Industry Outlook 4.1 market Snapshot 4.2 Global POC Blood Gas and Electrolyte Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global market, by region, 2021 - 2030 (USD Million) 4.4 Product Type Business Analysis 4.4.1 Global market, By Product Type, 2021 - 2030 (USD Million) 4.5 End-User Business Analysis 4.5.1 Global market, By End-User, 2021 - 2030 (USD Million) 4.6 Value Chain Analysis 4.7 market Variable Analysis 4.7.1 market Drivers Analysis 4.7.2 market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 market PEST analysis 4.8.2 market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2021) 5.11.2. Trends in Technology (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Consumables 7.3.1. Consumables market, 2021 - 2030 (USD Million) 7.3.1.1 Cartridges market, 2021 - 2030 (USD Million) 7.3.1.2 Reagents market, 2021 - 2030 (USD Million) 7.3.1.3 Others market, 2021 - 2030 (USD Million) 7.4. Instruments 7.4.1. Instruments market, 2021 - 2030 (USD Million) 7.4.1.1 Benchtop market, 2021 - 2030 (USD Million) 7.4.1.2 Portable market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and Clinics 8.3.1. Hospitals and Clinics market, 2021 - 2030 (USD Million) 8.4. Home Care 8.4.1. Home Care market, 2021 - 2030 (USD Million) 8.5 Research Institutes 8.5.1 Research Institutes market, 2021 - 2030 (USD Million) 8.6 Others 8.6.1 Others market, 2021 - 2030 (USD Million) 9. Global Market: Regional Outlook 9.1 North America 9.1.1. North America market, By Product Type, 2021 - 2030 (USD Million) 9.1.4. North America market, By End-User, 2021 - 2030 (USD Million) 9.1.5. North America market, by Country, 2021 - 2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. market, By Product Type, 2021 - 2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada market, By Product Type, 2021 - 2030 (USD Million) 9.1.4.2.2. Canada market, By Region, 2021 - 2030 (USD Million) 9.1.4.2.3. Canada market, by End-Users, 2021 - 2030 (USD Million) 9.2. Europe 9.2.1. Europe market, By Product Type, 2021 - 2030 (USD Million) 9.2.2. Europe market, By End-User, 2021 - 2030 (USD Million) 9.2.5. Europe market, by country, 2021 - 2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.1.2. U.K. market, By End-Users, 2021 - 2030 (USD Million) 9.2.4.1.3. U.K. market, by Region, 2021 - 2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.2.2. Germany market, By End-User, 2021 - 2030 (USD Million) 9.2.4.2.3. Germany market, by Region, 2021 - 2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.3.2. France market, By Region, 2021 - 2030 (USD Million) 9.2.4.3.3. France market, by End-User, 2021 - 2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.4.2. Rest of Europe market, By Region, 2021 - 2030 (USD Million) 9.2.4.4.3. Rest of Europe market, by End-User, 2021 - 2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific market, By Product Type, 2021 - 2030 (USD Million) 9.3.2. Asia Pacific market, By End-User, 2021 - 2030 (USD Million) 9.3.5. Asia Pacific market, by country, 2021 - 2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.1.2. China market, By Region, 2021 - 2030 (USD Million) 9.3.4.1.3. China market, by End-User, 2021 - 2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.2.2. India market, By Region, 2021 - 2030 (USD Million) 9.3.4.2.3. India market, by End-User, 2021 - 2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.3.3. Japan market, by End-User, 2021 - 2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.4.3. South Korea market, by End-User, 2021 - 2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC market, by End-User, 2021 - 2030 (USD Million) 9.4. Latin America 9.4.1. Latin America market, By Product Type, 2021 - 2030 (USD Million) 9.4.3. Latin America market, by End-User, 2021 - 2030 (USD Million) 9.4.4. Latin America market, by country, 2021 - 2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil market, By Product Type, 2021 - 2030 (USD Million) 9.4.4.1.3. Brazil market, by End-User, 2021 - 2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico market, By Product Type, 2021 - 2030 (USD Million) 9.4.4.2.3. Mexico market, by End-User, 2021 - 2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America market, By Product Type, 2021 - 2030 (USD Million) 9.4.4.3.3. Rest of the Latin America market, by End-User, 2021 - 2030 (USD Million) 9.5. MEA 9.5.1. MEA market, By Product Type, 2021 - 2030 (USD Million) 9.5.3. MEA market, by End-User, 2021 - 2030 (USD Million) 10. Competitive Landscape 10.1 Nova Biomedical. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Product Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Bayer. 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. Fortress Diagnostics. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Edan Instruments. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. F. Hoffmann-La Roche. 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. Erba Diagnostics. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. Medica. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Radiometer. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. JOKOH. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Abbott. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. Convergent Technologies. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. LifeHealth. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. Instrumentation Laboratory. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. Cornley. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development List of Tables (55 Tables) TABLE 1. market, By Product Type, 2021-2030 (USD Million) TABLE 2. market FOR Consumables, BY REGION, 2021-2030 (USD Million) TABLE 3. market FOR Cartridges, BY REGION, 2021-2030 (USD Million) TABLE 4. market FOR Reagents, BY REGION, 2021-2030 (USD Million) TABLE 5. market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 6. market FOR Instruments, BY REGION, 2021-2030 (USD Million) TABLE 7. market FOR Benchtop, BY REGION, 2021-2030 (USD Million) TABLE 8. market FOR Portable, BY REGION, 2021-2030 (USD Million) TABLE 9. market, BY END-USER, 2021-2030 (USD Million) TABLE 10. market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 11. market FOR Home Care, BY REGION, 2021-2030 (USD Million) TABLE 12. market FOR Research Institutes, BY REGION, 2021-2030 (USD Million) TABLE 13. market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 14. market, BY REGION, 2021-2030 (USD Million) TABLE 15. NORTH AMERICA market, BY COUNTRY, 2021-2030 (USD Million) TABLE 16. NORTH AMERICA market, BY End-Users, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA market, By Product Type, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA market, BY END-USER, 2021-2030 (USD Million) TABLE 19. EUROPE market, BY COUNTRY, 2021-2030 (USD Million) TABLE 20. EUROPE market, By Product Type, 2021-2030 (USD Million) TABLE 21. EUROPE market, BY END-USER, 2021-2030 (USD Million) TABLE 22. ASIA-PACIFIC market, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. ASIA-PACIFIC market, By Product Type, 2021-2030 (USD Million) TABLE 24. ASIA-PACIFIC market, BY END-USER, 2021-2030 (USD Million) TABLE 25. LAMEA market, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. LAMEA market, By Product Type, 2021-2030 (USD Million) TABLE 27. LAMEA market, BY END-USER, 2021-2030 (USD Million) TABLE 28. Nova Biomedical: COMPANY SNAPSHOT TABLE 29. Nova Biomedical: OPERATING SEGMENTS TABLE 30. Bayer: COMPANY SNAPSHOT TABLE 31. Bayer: OPERATING SEGMENTS TABLE 32. Fortress Diagnostics: COMPANY SNAPSHOT TABLE 33. Fortress Diagnostics: OPERATING SEGMENTS TABLE 34. Edan Instruments: COMPANY SNAPSHOT TABLE 35. Edan Instruments: OPERATING SEGMENTS TABLE 36. F. Hoffmann-La Roche: COMPANY SNAPSHOT TABLE 37. F. Hoffmann-La Roche: OPERATING SEGMENTS TABLE 38. Erba Diagnostics: COMPANY SNAPSHOT TABLE 39. Erba Diagnostics: OPERATING SEGMENTS TABLE 40. Medica: COMPANY SNAPSHOT TABLE 41. Medica: OPERATING SEGMENTS TABLE 42. Radiometer: COMPANY SNAPSHOT TABLE 43. Radiometer: OPERATING SEGMENTS TABLE 44. JOKOH: COMPANY SNAPSHOT TABLE 45. JOKOH: OPERATING SEGMENTS TABLE 46. Abbott: COMPANY SNAPSHOT TABLE 47. Abbott: OPERATING SEGMENTS TABLE 48. Convergent Technologies: COMPANY SNAPSHOT TABLE 49. Convergent Technologies: OPERATING SEGMENTS TABLE 50. LifeHealth: COMPANY SNAPSHOT TABLE 51. LifeHealth: OPERATING SEGMENTS TABLE 52. Instrumentation Laboratory: COMPANY SNAPSHOT TABLE 53. Instrumentation Laboratory: OPERATING SEGMENTS TABLE 54. Cornley: COMPANY SNAPSHOT TABLE 55. Cornley: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: market Figure 4 Research Methodology: Hypothesis Building Figure 5 market: Product-Based Estimation Figure 6 Top 14 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for POC Blood Gas and Electrolyte, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for POC Blood Gas and Electrolyte, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 market, By End-Users, 2019 vs. 2025 (USD Million) Figure 12 market Share, By Product Type, 2019 vs. 2025 Figure 13 Geographical Snapshot of the market Figure 14 consumables to Witness Higher CAGR in market for Product Type Segment during Forecast Period. Figure 15 Hospitals and Clinics to Witness Higher CAGR in market for End-User Segment during Forecast Period. Figure 16 North America Accounted for the Largest Share of the market, By Regional Basis, in 2019 Figure 17 market: Drivers, Restraints, Opportunities, and Challenges Figure 18 North America: market Snapshot Figure 19 Asia Pacific: market Snapshot Figure 20 Vendor Dive: Evaluation Overview